Bantam Pharmaceuticals
Clinical trials sponsored by Bantam Pharmaceuticals, explained in plain language.
-
New cancer drug BTM-3566 enters human testing
Disease control Recruiting nowThis early-stage trial tests a new drug called BTM-3566 in 30 adults with advanced solid tumors that have not responded to standard treatments. The main goal is to find safe doses and understand side effects. Participants take the drug for 7 days followed by a 7-day break, repeat…
Phase: PHASE1 • Sponsor: Bantam Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 00:47 UTC
-
New hope for lymphoma patients: experimental drug BTM-3566 enters human testing
Disease control Recruiting nowThis early-phase trial tests a new drug called BTM-3566 in 24 adults whose B-cell lymphoma has returned or not responded to treatment. The main goals are to check safety, find the right dose, and see if the drug can slow or stop the cancer. Participants take the drug in 14-day cy…
Phase: PHASE1 • Sponsor: Bantam Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 16:01 UTC